drugset / Trial / NCT00554658
Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients
NaSingle-groupOpen-label
Summary
Aim of the study is to assess the effect of quetiapine treatment in neuroleptic naive, first-episode schizophrenic patients on aspects of functional and structural neuroplasticity assessed by means of transcranial magnetic stimulation and voxel-based morphometry. Main outcome measure is a change in gray matter density under quetiapine treatment from baseline to steady-state-treatment after 3 weeks.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-12
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quetiapine | Small molecule | 400 mg | — |
| Comparator | Quetiapine | Small molecule | 800 mg | — |